128 related articles for article (PubMed ID: 16056250)
1. Expression of CD117 (c-kit) receptor in dysgerminoma of the ovary: diagnostic and therapeutic implications.
Sever M; Jones TD; Roth LM; Karim FW; Zheng W; Michael H; Hattab EM; Emerson RE; Baldridge LA; Cheng L
Mod Pathol; 2005 Nov; 18(11):1411-6. PubMed ID: 16056250
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of c-KIT mutations in gonadoblastoma and dysgerminomas of patients with disorders of sex development (DSD) and ovarian dysgerminomas.
Hersmus R; Stoop H; van de Geijn GJ; Eini R; Biermann K; Oosterhuis JW; Dhooge C; Schneider DT; Meijssen IC; Dinjens WN; Dubbink HJ; Drop SL; Looijenga LH
PLoS One; 2012; 7(8):e43952. PubMed ID: 22937135
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic utility of CD117, CD133, SALL4, OCT4, TCL1 and glypican-3 in malignant germ cell tumors of the ovary.
Trinh DT; Shibata K; Hirosawa T; Umezu T; Mizuno M; Kajiyama H; Kikkawa F
J Obstet Gynaecol Res; 2012 May; 38(5):841-8. PubMed ID: 22448662
[TBL] [Abstract][Full Text] [Related]
4. [Expression and diagnostic significance of OCT4, CD117 and CD30 in germ cell tumors].
Teng LH; Lu DH; Xu QZ; Fu YJ; Yang H; He ZL
Zhonghua Bing Li Xue Za Zhi; 2005 Nov; 34(11):711-5. PubMed ID: 16536313
[TBL] [Abstract][Full Text] [Related]
5. OCT4: a novel biomarker for dysgerminoma of the ovary.
Cheng L; Thomas A; Roth LM; Zheng W; Michael H; Karim FW
Am J Surg Pathol; 2004 Oct; 28(10):1341-6. PubMed ID: 15371950
[TBL] [Abstract][Full Text] [Related]
6. c-KIT codon 816 mutation in a recurrent and metastatic dysgerminoma of a 14-year-old girl: case study.
Pauls K; Wardelmann E; Merkelbach-Bruse S; Büttner R; Zhou H
Virchows Arch; 2004 Dec; 445(6):651-4. PubMed ID: 15455230
[TBL] [Abstract][Full Text] [Related]
7. Cytokeratin and CD30 expression in dysgerminoma.
Cossu-Rocca P; Jones TD; Roth LM; Eble JN; Zheng W; Karim FW; Cheng L
Hum Pathol; 2006 Aug; 37(8):1015-21. PubMed ID: 16867864
[TBL] [Abstract][Full Text] [Related]
8. Differentiation potential of ovarian dysgerminoma: an immunohistochemical study of 15 cases.
Lifschitz-Mercer B; Walt H; Kushnir I; Jacob N; Diener PA; Moll R; Czernobilsky B
Hum Pathol; 1995 Jan; 26(1):62-6. PubMed ID: 7821917
[TBL] [Abstract][Full Text] [Related]
9. Ovarian dysgerminomas are characterised by frequent KIT mutations and abundant expression of pluripotency markers.
Hoei-Hansen CE; Kraggerud SM; Abeler VM; Kaern J; Rajpert-De Meyts E; Lothe RA
Mol Cancer; 2007 Feb; 6():12. PubMed ID: 17274819
[TBL] [Abstract][Full Text] [Related]
10. Lack of expression of c-kit protein (CD117) in mesenchymal tumors of the uterus and ovary.
Klein WM; Kurman RJ
Int J Gynecol Pathol; 2003 Apr; 22(2):181-4. PubMed ID: 12649674
[TBL] [Abstract][Full Text] [Related]
11. Expression of Sox10 and c-kit in sinonasal mucosal melanomas arising in the Chinese population.
Liu HG; Kong MX; Yao Q; Wang SY; Shibata R; Yee H; Martiniuk F; Wang BY
Head Neck Pathol; 2012 Dec; 6(4):401-8. PubMed ID: 22736149
[TBL] [Abstract][Full Text] [Related]
12. Gonadoblastoma: evidence for a stepwise progression to dysgerminoma in a dysgenetic ovary.
Pauls K; Franke FE; Büttner R; Zhou H
Virchows Arch; 2005 Sep; 447(3):603-9. PubMed ID: 15968543
[TBL] [Abstract][Full Text] [Related]
13. Kit expression in spindle cell rhabdomyosarcoma can possibly create a different approach for its tumorigenesis and therapy.
Diniz G; Aktas S; Ortac R; Tunakan M; Unlu I; Vergin C
Pathol Res Pract; 2006; 202(9):671-7. PubMed ID: 16860492
[TBL] [Abstract][Full Text] [Related]
14. CD117 expression in breast phyllodes tumors correlates with adverse pathologic parameters and reduced survival.
Tan WJ; Thike AA; Tan SY; Tse GM; Tan MH; Bay BH; Tan PH
Mod Pathol; 2015 Mar; 28(3):352-8. PubMed ID: 25216225
[TBL] [Abstract][Full Text] [Related]
15. Preferential localization of c-kit product in tissue mast cells, basal cells of skin, epithelial cells of breast, small cell lung carcinoma and seminoma/dysgerminoma in human: immunohistochemical study on formalin-fixed, paraffin-embedded tissues.
Tsuura Y; Hiraki H; Watanabe K; Igarashi S; Shimamura K; Fukuda T; Suzuki T; Seito T
Virchows Arch; 1994; 424(2):135-41. PubMed ID: 7514077
[TBL] [Abstract][Full Text] [Related]
16. Comparison of immunohistochemical profiles of ovarian germ cells in dysgerminomas of a captive maned wolf and domestic dogs.
Rosa RB; Bianchi MV; Ribeiro PR; Argenta FF; Vielmo A; de Sousa FAB; Piva MM; Pohl CB; Daoualibi Y; Cony FG; Brunner CB; Von Hohendorff R; Sonne L
J Vet Diagn Invest; 2021 Jul; 33(4):772-776. PubMed ID: 34047229
[TBL] [Abstract][Full Text] [Related]
17. KIT gene mutation and amplification in dysgerminoma of the ovary.
Cheng L; Roth LM; Zhang S; Wang M; Morton MJ; Zheng W; Abdul Karim FW; Montironi R; Lopez-Beltran A
Cancer; 2011 May; 117(10):2096-103. PubMed ID: 21523721
[TBL] [Abstract][Full Text] [Related]
18. D2-40 immunohistochemistry in the differential diagnosis of seminoma and embryonal carcinoma: a comparative immunohistochemical study with KIT (CD117) and CD30.
Lau SK; Weiss LM; Chu PG
Mod Pathol; 2007 Mar; 20(3):320-5. PubMed ID: 17277761
[TBL] [Abstract][Full Text] [Related]
19. COX-2 expression in nonepithelial ovarian malignancies.
Menczer J; Schreiber L; Sukmanov O; Czernobilsky B; Berger E; Golan A; Levi T
Int J Gynecol Pathol; 2011 Jan; 30(1):41-5. PubMed ID: 21131835
[TBL] [Abstract][Full Text] [Related]
20. Chromosome 12p abnormalities in dysgerminoma of the ovary: a FISH analysis.
Cossu-Rocca P; Zhang S; Roth LM; Eble JN; Zheng W; Karim FW; Michael H; Emerson RE; Jones TD; Hattab EM; Cheng L
Mod Pathol; 2006 Apr; 19(4):611-5. PubMed ID: 16554737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
